Plenty of KOL calls on $LQDA, one more from RBC. Treats 700 patients. Doc is now 70% Yutrepria/30% Tyvaso DPI in ILD patients, in PAH using more Yutrepria vs DPI
@wusatiuk Is the downside just from over-subscribed potential? I would guess the premium continues to compress as we get closer to the expiration date, still may get ~7% return if you sell before expiration, nice for a 2-week hold
The $OMCC vol has been strange. Since Dec 23, ~30% of total shares have turned over with the stock going from $5 to ~$3. This was the old $NICK, which sold the core and then invested into broadband Amplex Electric (they hold just over 60%)
catching up on the $CODI transcript from yest (whole house is sick, I'm so far behind on things). No position in the common, I had a small position in the preferreds when they dumped. This Lugano fraud is wild! Rev 85% lower than thought